Media Room

The nasal spray Neffy is the first non-injectable epinephrine to treat the life-threatening allergic response

Food Protein-Induced Enterocolitis Syndrome, known as FPIES, affects an estimated 90,000 people in the U.S. – about 5 in 1,000 children and 2 in 1,000 adults – and most parents have never heard of it.

Neffy is the first epinephrine product that’s needle-free.

It marks the first needle-free form of epinephrine for serious allergic reactions to food, medications and insect stings.

Food Protein-Induced Enterocolitis Syndrome, known as FPIES, affects an estimated 90,000 people in the U.S. – about 5 in 1,000 children and 2 in 1,000 adults – and most parents have never heard of it.

Airlines, restaurants and hotels offering customized care for people with sensitivities to foods like peanuts, wheat and milk, but it’s still critical to be your own advocate